Stay updated on Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.

Latest updates to the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe record history now includes a new version entry for v3.6.3 and removes the previous v3.6.2 entry, signaling an updated revision of the study record. This update documents the latest revision in the history.SummaryDifference0.1%

- Check25 days agoChange DetectedA new revision entry (v3.6.2) was added to the study record history, and the previous revision (v3.6.0) was removed. This reflects an update to the documentation of the page's history.SummaryDifference0.1%

- Check39 days agoChange DetectedThe record history now shows explicit 'Last verified' and 'Last known status was' with a new 'Revision: v3.6.0', replacing the previous labels and the older revision 'v3.5.5'.SummaryDifference3%

- Check46 days agoChange DetectedThe study history shows a new revision entry (v3.5.5) and the previous revision (v3.5.4) is removed from the history list, updating the visible record of changes.SummaryDifference0.1%

- Check67 days agoChange DetectedAdded a new Revision: v3.5.4 entry to the Study Record History, replacing the previous Revision: v3.5.3 entry and indicating an update to the page's version history.SummaryDifference0.1%

- Check89 days agoChange DetectedThis update reflects a revision/version bump on the ClinicalTrials.gov page (v3.5.0 → v3.5.3), with no accompanying changes to the displayed study record history content.SummaryDifference0.1%

Stay in the know with updates to Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.